Recognized in the 2017 edition of Lawdragon 500 as a leading lawyer in America.

Recognized in the 2014 Washington, D.C. Super Lawyers list.

Abid R. Qureshi

Washington, D.C.
  • 555 Eleventh Street, NW
  • Suite 1000
  • Washington, D.C. 20004-1304
  • USA
 
 

Abid Qureshi is a partner in Latham & Watkins’ Litigation & Trial Department in the Washington, D.C. office. He is the global Chair of Latham’s Pro Bono Committee and previously served as Co-chair for the Washington, D.C. office Litigation & Trial Department.

Mr. Qureshi has particular expertise in matters involving allegations of:

  • False Claims Act liability
  • Violations of the federal securities laws
  • Healthcare fraud and abuse

Mr. Qureshi is an experienced trial lawyer who has served as lead counsel in numerous trials before federal and state courts throughout the country. He has represented clients in state and federal courts (at the district and appellate levels), national and international arbitral tribunals and before state and federal regulators.

In addition to his commercial litigation experience, Mr. Qureshi has substantial experience handling internal corporate investigations, governmental inquiries and regulatory proceedings. He has particular facility with managing large multi-faceted investigations on behalf of international companies. He is listed as a "leading lawyer in America" by Lawdragon 500 2017 and is recognized in the 2014 Washington, D.C. Super Lawyers list, which recognizes individuals who have distinguished themselves in their legal practice.

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.